Tocilizumab effectiveness in mechanically ventilated COVID-19 patients (T-MVC-19 Study): a multicenter real-world evidence-Reference-Cited by-同舟云学术

Tocilizumab effectiveness in mechanically ventilated COVID-19 patients (T-MVC-19 Study): a multicenter real-world evidence

Published:2022-03-07 Issue:7 Volume:20 Page:1037-1047
ISSN:1478-7210
Container-title:Expert Review of Anti-infective Therapy
language:en
Short-container-title:Expert Review of Anti-infective Therapy

Author:

Mohzari Yahya A.¹,Alamer Ahmad²^ORCID,Alattas Majda³,Alrashed Ahmed A.⁴,Alshehab Nura A.⁵^ORCID,Alkhaldi Turkiah K.⁶,Alamer Amnah A.⁷,Asdaq Syed M.B⁸^ORCID,Aljefri Doaa⁹,Alajami Hamdan N.¹⁰,Alsowaida Yazed S.¹¹^ORCID,Mathew Maya¹²,AlMusawa Mohammed I.¹³,Alomar Mukhtar¹⁴,Alharbi Raghad Y.¹⁵,Khuwaja Malik¹⁶,Bamogaddam Reem F.¹²,Alharthi Ashwaq H.¹⁷,Faqihi Aisha Y.¹⁸,Alrumayyan Bashayer F.¹⁸,Alshareef Abeer¹⁷,Alhassan Batool M.¹⁹,Damfu Nader Y.²⁰,Alajmi Ghada S.¹⁷,Albujaidy Asma²¹,Alghalbi Maram²²,Alajlan Saleh A²³,Abraham Ivo²⁴^ORCID,Almulhim Abdulaziz S.²⁵^ORCID

Affiliation:

1. Department of Clinical Pharmacy, King Faisal Specialist Hospital and Research Center, Jeddah, Saudi Arabia; King Saud Medical City, Riyadh, Saudi Arabia

2. Department of Clinical Pharmacy, Prince Sattam Bin Abdulaziz University, Alkharj, Saudi Arabia; Center for Health Outcomes and PharmacoEconomic Research, University of Arizona, Tucson, AZ, USA

3. Department of Clinical Pharmacy, King Faisal Specialist Hospital and Research Center, Jeddah, Saudi Arabia

4. Department of Pharmaceutical Services, Main hospital, King Fahad Medical City, Riyadh, Saudi Arabia

5. Department of Pharmacy, Al-Ahsa Hospital, Al-Ahsa, Saudi Arabia

6. Department of Pharmaceutical Service, Main Pharmacy, King Fahad Medical City, Riyadh, Saudi Arabia

7. Department of Internal Medicine, King Faisal University, Al-Ahsa, Saudi Arabia; Department of Infectious Diseases, McMaster University, Hamilton, Ohio, Canada

8. Department of Pharmacy Practice, College of Pharmacy, AlMaarefa University, Riyadh, Saudi Arabia

9. Department of Pharmacy, King Abdulaziz Medical City, Jeddah, Saudi Arabia

10. Pharmaceutical Care Department, King Saud Medical City, Riyadh, Saudi Arabia

11. Department of Clinical Pharmacy, College of Pharmacy, Hail University, Hail, Saudi Arabia; Department of Pharmacy, Brigham and Women’s Hospital, Boston, MA, USA

12. Department of Clinical Pharmacy, King Saud Medical City, Riyadh, Saudi Arabia

13. Division of Pharmaceutical Care, King Faisal Specialist Hospital and Research Centre, Jeddah, Saudi Arabia

14. Dammam Medical Complex, First Health Cluster in Eastern Province, Saudi Arabia

15. Department of Clinical Pharmacy, Princess Nourah Bint Abdulrahman University, Riyadh, Saudi Arabia

16. Division of Pharmaceutical Care, King Faisal Specialist Hospital and Research Center, Jeddah, Saudi Arabia

17. Department of Pharmacy Services, King Saud University Medical City, Riyadh, Saudi Arabia

18. Department of Pharmacy, King Fahad Medical City, Riyadh, Saudi Arabia

19. Department of Clinical Pharmacy, Almoosa Specialist Hospital, Al-Ahasa, Saudi Arabia

20. Department of Pharmaceutical Care, King Abdulaziz Medical City, Jeddah, Saudi Arabia

21. Department of Clinical Pharmacy Service, Prince Mohammed bin Abdulaziz Hospital, Riyadh, Saudi Arabia

22. Department of Pharmaceutical Services, Clinical Pharmacy, Prince Sultan Military Medical City, Riyadh, Saudi Arabia

23. Department of Pediatric Dentistry, King Fahad Medical City, Riyadh, Saudi Arabia

24. Center for Health Outcomes and PharmacoEconomic Research, University of Arizona, Tucson, AZ, USA; Department of Pharmacy Practice and Science, College of Pharmacy, University of Arizona, Tucson, AZ, USA

25. Department of Pharmacy Practice, College of Clinical Pharmacy, King Faisal University, Al-Ahsa, Saudi Arabia

Publisher

Informa UK Limited

Subject

Virology,Infectious Diseases,Microbiology (medical),Microbiology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14787210.2022.2046462

Reference75 articles.

1. Clinical Characteristics of Coronavirus Disease 2019 in China

2. World Health Organization: Coronavirus Disease 2019 (COVID-19) situation report - 66 [Internet]. World Health Organization

3. 2020 [cited 2021 Aug 06]. Available from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200326-sitrep-66-covid-19.pdf?sfvrsn=81b94e61_2

4. World Health Organization: WHO coronavirus disease (COVID-19) dashboard [Internet]. World Health Organization; 2020 [updated 2021 Dec 10; cited 2021 Aug 06]. Available from: https://covid19.who.int/

5. COVID-19 fatality rates in hospitalized patients: systematic review and meta-analysis

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. “Ventilator-free days” composite outcome in patients with SARS-CoV-2 infection treated with tocilizumab: A retrospective competing risk analysis;Heart & Lung;2022-11

2. Efficacy and safety of baricitinib and tocilizumab in hospitalized patients with COVID-19: A comparison using systematic review and meta-analysis;Frontiers in Pharmacology;2022-10-14